Opportunities exist in developing IGF-1R-targeted therapies for thyroid eye disease with proven market potential, and revisiting oncology applications using biomarker-driven patient stratification and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback